Literature DB >> 10931133

CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.

M Boesen1, I M Svane, A M Engel, J Rygaard, A R Thomsen, O Werdelin.   

Abstract

An attempt was made to identify the selection pressures put upon a growing tumour by CD8+ T cells. To this end tumours induced with 3-methylcholanthrene in T cell-deficient nude mice and in congenic T cell-competent nu/+ mice were transplanted to nu/+ recipients. The rejection rate of the sarcomas from nude mice was almost twice that of the sarcomas from nu/+ mice. Depletion of CD8+ T cells from nu/+ recipients prior to transplantation made them accept nude tumours that were consistently rejected by untreated nu/+ recipients. These findings suggest that a methylcholanthrene sarcoma during its growth in a T cell-competent host adapts to the T cell system through a selective elimination of highly immunogenic tumour cells that are susceptible to CD8+ T cell-mediated lysis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931133      PMCID: PMC1905705          DOI: 10.1046/j.1365-2249.2000.01292.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

Review 1.  Emerging role of heat shock proteins in biology and medicine.

Authors:  M Jäättelä; D Wissing
Journal:  Ann Med       Date:  1992-08       Impact factor: 4.709

2.  The nude mouse vs. the hypothesis of immunological surveillance.

Authors:  J Rygaard; C O Povlsen
Journal:  Transplant Rev       Date:  1976

3.  Role of different T cells sets in the rejection of syngeneic chemically induced tumors.

Authors:  K Shimizu; F W Shen
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

Review 4.  The concept of immunological surveillance.

Authors:  F M Burnet
Journal:  Prog Exp Tumor Res       Date:  1970

Review 5.  Role of the major histocompatibility complex class I antigens in tumor growth and metastasis.

Authors:  K Tanaka; T Yoshioka; C Bieberich; G Jay
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

6.  Failure of immunogenic tumors to elicit cytolytic T cells in syngeneic hosts.

Authors:  D S Nelson; K E Hopper; R V Blanden; I D Gardner; R Kearney
Journal:  Cancer Lett       Date:  1978-08       Impact factor: 8.679

Review 7.  Proteolysis. The proteasome: a protein-degrading organelle?

Authors:  D M Rubin; D Finley
Journal:  Curr Biol       Date:  1995-08-01       Impact factor: 10.834

8.  Immunostimulation of highly immunogenic target tumor cells by lymphoid cells in vitro.

Authors:  L M Prehn
Journal:  J Natl Cancer Inst       Date:  1976-04       Impact factor: 13.506

9.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

Review 10.  Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function.

Authors:  P C Doherty; B B Knowles; P J Wettstein
Journal:  Adv Cancer Res       Date:  1984       Impact factor: 6.242

View more
  6 in total

1.  T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokine.

Authors:  Moses K Donkor; Abira Sarkar; Peter A Savage; Ruth A Franklin; Linda K Johnson; Achim A Jungbluth; James P Allison; Ming O Li
Journal:  Immunity       Date:  2011-07-14       Impact factor: 31.745

2.  HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.

Authors:  María A Garrido; Teresa Rodriguez; Svitlana Zinchenko; Isabel Maleno; Francisco Ruiz-Cabello; Ángel Concha; Nicolás Olea; Federico Garrido; Natalia Aptsiauri
Journal:  Immunogenetics       Date:  2018-08-25       Impact factor: 2.846

Review 3.  Cancer immune escape: MHC expression in primary tumours versus metastases.

Authors:  Federico Garrido; Natalia Aptsiauri
Journal:  Immunology       Date:  2019-10-01       Impact factor: 7.397

Review 4.  The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture.

Authors:  Federico Garrido; Francisco Perea; Mónica Bernal; Abel Sánchez-Palencia; Natalia Aptsiauri; Francisco Ruiz-Cabello
Journal:  Vaccines (Basel)       Date:  2017-02-27

Review 5.  Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.

Authors:  Karthik Dhatchinamoorthy; Jeff D Colbert; Kenneth L Rock
Journal:  Front Immunol       Date:  2021-03-09       Impact factor: 7.561

6.  A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.

Authors:  Nadine Y Crowe; Mark J Smyth; Dale I Godfrey
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.